background
nanoparticl
becom
key
technolog
multipl
industri
howev
grow
report
toxic
nanomateri
human
particular
nanomateri
link
lung
diseas
molecular
mechan
nanoparticl
toxic
larg
unexplor
method
acut
lung
injuri
induc
wildtyp
mice
angiotensincovert
enzym
knockout
mice
intratrach
instil
cation
polyamidoamin
dendrim
pamam
nanoparticl
rescu
experi
losartan
mgkg
pb
inject
intraperiton
min
nanoparticl
administr
result
pamam
nanoparticl
anion
pamam
nanoparticl
carbon
nanotub
trigger
acut
lung
failur
mice
mechanist
cation
nanoparticl
directli
bind
decreas
activ
downregul
express
level
lung
tissu
result
deregul
reninangiotensin
system
gene
inactiv
exacerb
lung
injuri
importantli
administr
losartan
angiotensin
ii
type
receptor
antagonist
amelior
pamam
nanoparticleinduc
lung
injuri
conclus
data
provid
molecular
insight
pamam
nanoparticleinduc
lung
injuri
suggest
potenti
therapeut
screen
strategi
address
safeti
nanomateri
nanoparticl
becom
key
materi
pharmaceut
inform
commun
industri
well
multipl
area
requir
strong
light
materi
howev
sever
concern
rais
safeti
widespread
use
nanoparticl
among
concern
potenti
toxic
nanoparticl
human
among
distress
nanomateri
report
harm
cellular
subcellular
protein
level
found
elicit
injuri
respons
variou
organ
mani
studi
focus
lung
diseas
includ
clinic
studi
worker
develop
pulmonari
diseas
nanoparticl
exposur
worldwid
moratorium
nanomateri
even
call
safeti
issu
resolv
nanoparticl
safeti
respiratori
system
import
worker
high
exposur
particl
also
pulmonari
drug
nanoparticl
serv
vehicl
directli
lung
therefor
critic
import
elucid
molecular
mechan
nanoparticl
induc
lung
injuri
polyamidoamin
pamam
dendrim
famili
dendrit
polym
base
ethylenediamin
core
repeat
amidoamin
branch
pamam
dendrim
grow
gener
g
repres
gener
dendrim
base
ethylenediamin
core
repeat
amidoamin
branch
size
increas
nm
pamam
dendrim
commerci
avail
either
whole
cation
half
anion
gener
polym
low
polydispers
index
abil
precis
control
surfac
chemistri
make
dendrim
use
biomedicin
applic
drug
gene
deliveri
diagnost
imag
exampl
pamam
dendrim
use
inhibit
inflamm
improv
therapeut
respons
cancer
suppress
infect
addit
pamam
dendrim
also
use
nanocarri
pulmonari
drug
deliveri
effect
vector
pulmonari
gene
transfer
mani
pamam
nanoparticl
consid
carrier
pulmonari
drug
deliveri
addit
studi
report
pamam
found
major
organ
highest
level
lung
melanoma
human
prostat
cancer
mous
tumor
model
safeti
pamam
nanoparticl
rigor
assess
evalu
previou
report
indic
pamam
dendrim
toxic
toxic
significantli
influenc
size
surfac
charg
specif
charg
nanoparticl
also
affect
oral
toxic
pamam
dendrim
furthermor
pamam
dendrim
demonstr
aggress
initi
blood
clot
format
disrupt
key
platelet
function
although
system
oral
toxic
pamam
nanoparticl
investig
studi
focus
safeti
pamam
nanoparticl
respiratori
system
consid
potenti
biomed
applic
pamam
nanoparticl
especi
applic
pulmonari
diseas
paramount
investig
underli
molecular
mechan
may
involv
pamaminduc
lung
injuri
vivo
determin
whether
pamam
induc
lung
injuri
mice
test
differ
gener
pamam
via
intratrach
administr
approach
vivo
detail
physicalchem
characterist
pamam
use
studi
list
addit
file
tabl
pamam
dendrim
induc
sever
lung
injuri
evidenc
increas
wettodri
weight
ratio
measur
lung
edema
inflamm
figur
among
test
nanoparticl
high
gener
cation
pamam
nanoparticl
induc
sever
alter
lung
wherea
low
gener
pamam
carboxyltermin
dendrim
show
acut
toxicolog
result
consist
previou
studi
pamam
nanoparticl
diamet
approxim
nm
exhibit
sever
acut
lung
injuri
focus
pamam
nanoparticl
subsequ
experi
also
test
acut
toxicolog
pamam
nanoparticl
vivo
result
show
pamam
nanoparticl
confid
limit
tabl
first
examin
surviv
rate
mice
administr
pamam
dendrim
lung
almost
mice
treat
pamam
nanoparticl
die
within
hr
wherea
control
mice
mice
instil
anion
pamam
dendrim
surviv
figur
caus
death
rapid
develop
sever
lung
injuri
character
decreas
blood
oxygen
figur
increas
lung
tissu
wettodri
weight
ratio
figur
massiv
alter
elast
figur
lung
elast
measur
lung
function
ie
chang
pressur
per
unit
chang
volum
indic
stiff
lung
histopatholog
pamamtr
lung
show
increas
bleed
inflammatori
cell
infiltr
figur
moreov
pamam
administr
result
increas
vascular
permeabl
figur
anoth
hallmark
acut
lung
injuryrespiratori
distress
syndrom
human
result
indic
inhal
pamam
nanoparticl
induc
acut
lung
injuri
mice
result
patholog
resembl
acut
respiratori
distress
syndrom
human
previous
discov
role
protect
mice
sever
acut
lung
injuri
proteolyt
cleav
angiotensin
ii
angii
therebi
neg
regul
reninangiotensin
system
ra
induct
acut
lung
injuri
acid
aspir
sepsi
sarscov
result
downregul
express
mous
lung
tissu
subsequ
upregul
angii
also
report
plasma
angii
level
link
diseas
sever
predict
fatal
outcom
patient
therefor
test
whether
ra
also
affect
nanoparticleinduc
lung
injuri
mice
serum
angii
level
measur
mice
follow
inhal
pamam
nanomateri
figur
addit
file
figur
addit
mrna
figur
protein
level
lung
determin
figur
addit
file
figur
ra
system
markedli
activ
demonstr
increas
serum
angii
level
mice
treat
cation
pamam
nanoparticl
pamam
particl
greatest
effect
figur
moreov
inhal
pamam
dendrim
result
signific
downregul
protein
express
lung
tissu
pamam
induc
greatest
effect
figur
inhal
pamam
nanoparticl
also
result
reduc
express
lung
although
differ
reach
statist
signific
notabl
lung
level
ace
enzym
gener
angii
appar
affect
pamam
inhal
figur
thu
pulmonari
administr
certain
pamam
nanoparticl
especi
pamam
markedli
activ
ra
via
downregul
express
elucid
mechan
downregul
first
explor
whether
loss
activ
caus
direct
bind
nanoparticl
assess
bind
affin
variou
nanoparticl
use
surfac
plasmon
reson
spr
interestingli
cation
pamam
could
bind
protein
directli
wherea
anion
pamam
fail
bind
figur
addit
file
figur
predict
sinc
theoret
isoelectr
point
protein
calcul
expasi
http
wwwexpasyorg
spr
assay
perform
neutral
ph
dynam
bind
constant
equilibrium
dissoci
constant
bind
examin
nanoparticl
also
measur
demonstr
pamam
nanoparticl
particular
strongli
bind
addit
file
tabl
next
monitor
enzym
activ
measur
angii
level
mix
recombin
protein
variou
nanoparticl
vitro
enzymat
activ
decreas
incub
cation
pamam
nanoparticl
activ
affect
incub
anion
pamam
vitro
figur
data
show
pamam
nanoparticl
directli
associ
alter
enzymat
activ
therebi
result
activ
ra
final
determin
whether
critic
role
acut
lung
injuri
follow
pamam
dendrim
administr
examin
mice
genet
defici
follow
administr
pamam
dendrim
mice
die
significantli
faster
wildtyp
control
mice
figur
addit
pamaminduc
chang
lung
elast
blood
oxygen
lung
tissu
wettodri
weight
ratio
lung
histopatholog
exacerb
mice
rel
control
anim
figur
data
indic
pamam
dendrim
induc
sever
acut
lung
failur
function
alter
ra
specif
via
downregul
next
test
whether
losartan
first
angiotensin
receptor
blocker
arb
approv
clinic
use
could
rescu
sever
lung
injuri
occur
follow
inhal
pamam
dendrim
importantli
administr
losartan
prolong
overal
surviv
time
pamamtr
wild
type
mice
figur
markedli
allevi
impair
lung
function
figur
attenu
increas
angii
product
figur
reduc
increas
wettodri
weight
ratio
lung
tissu
figur
improv
decreas
blood
oxygen
figur
measur
evan
blue
vascular
see
figur
previou
page
figur
pamam
dendrim
induc
sever
acut
lung
injuri
wettodri
weight
ratio
lung
administr
nanoparticl
hr
administr
n
mice
per
group
p
compar
group
vehicl
control
cohort
use
twotail
ttest
analysi
b
surviv
rate
n
mice
per
group
p
comparison
group
either
control
group
logrank
test
c
arteri
blood
partial
oxygen
pressur
pao
lung
wettodri
weight
ratio
hr
intratrach
instil
vehicl
control
n
mice
per
group
p
comparison
cohort
control
group
twotail
ttest
e
chang
lung
elast
follow
challeng
nanoparticl
vehicl
n
mice
per
group
anova
bonferroni
posthoc
analysi
f
repres
imag
lung
patholog
hr
administr
vehicl
control
nanoparticl
mean
number
infiltr
cell
per
microscop
field
sem
also
shown
n
field
analyz
three
mice
treatment
group
twotail
ttest
scale
bar
g
repres
imag
lung
inject
evan
blue
hr
challeng
nanoparticl
vehicl
control
amount
extravascular
evan
blue
determin
hr
inject
nanoparticl
vehicl
n
mice
per
group
twotail
ttest
data
shown
mean
valu
sem
except
surviv
curv
p
p
leakag
assay
losartan
also
significantli
decreas
vascular
permeabl
pulmonari
blood
vessel
pamamtr
mice
figur
addit
treatment
losartan
amelior
pamaminduc
lung
histopatholog
includ
bleed
inflamm
cell
infiltr
figur
furthermor
measur
classic
proinflammatori
cytokin
bronchoalveolar
lavag
fluid
balf
enzymelink
immuno
sorbent
assay
elisa
result
show
treatment
losartan
could
reduc
concentr
balf
instil
pamam
dendrim
figur
thu
nanoparticleinduc
lung
injuri
inhibit
administr
losartan
sinc
pamam
dendrim
downregul
express
mrna
protein
level
significantli
hr
instil
figur
b
c
death
mice
occur
hour
instil
pamam
figur
choos
timepoint
hr
instil
pamam
evalu
chang
lung
function
data
provid
vivo
molecular
insight
acut
lung
failur
induc
nanomateri
data
indic
pamam
dendrim
downregul
express
lung
tissu
result
increas
angii
product
consequ
acut
lung
failur
spr
data
show
pamam
protein
highest
bind
affin
addit
file
tabl
howev
pamam
amino
surfac
group
addit
file
tabl
suggest
nanoparticl
surfac
charg
determin
studi
conform
characterist
stabil
pamam
complex
need
studi
pamam
nanoparticl
could
induc
lung
edema
figur
wherea
lower
gener
cation
anion
pamam
dendrim
exhibit
acut
lung
toxic
result
consist
previou
find
state
nanoparticl
size
significantli
influenc
toxicolog
pamam
nanoparticl
interest
note
nanoparticl
effect
angii
level
exampl
pamam
dendrim
appear
less
toxic
pamam
dendrim
addit
studi
regard
entri
nanoparticl
pulmonari
epitheli
cell
andor
local
resid
macrophag
requir
explain
differ
nevertheless
minor
modif
nanomateri
appear
significantli
reduc
pulmonari
toxic
suggest
possibl
approach
enabl
safer
use
nanomateri
previous
shown
cation
pamam
nanoparticl
cooh
singlewal
carbon
nanotub
copper
oxid
nanoparticl
induc
autophagi
vitro
cell
model
vivo
mous
model
thu
sever
lung
injuri
trigger
pamam
nanoparticl
may
due
activ
multipl
signal
pathway
collect
caus
sever
lung
diseas
previou
studi
show
angii
could
increas
autophagi
level
via
activ
receptor
nadph
oxidas
vascular
muscl
cell
whether
signal
transduct
pathway
involv
pathogenesi
lung
failur
induc
pamam
nanoparticl
need
studi
new
data
clearli
establish
ra
play
key
role
pamam
nanoparticleinduc
lung
injuri
interestingli
mechan
also
appli
sever
acut
lung
injuri
associ
acid
aspir
sepsi
infect
sarscov
influenza
thu
parallel
mechan
suggest
ra
share
common
diseas
mechan
acut
lung
injuri
respiratori
distress
syndrom
modul
ra
may
wide
rang
therapeut
applic
develop
nanotechnolog
rapidli
acceler
estim
market
approxim
one
trillion
us
dollar
within
next
year
safeti
problem
associ
nanomateri
recent
attract
attent
highlight
urgent
need
protocol
protect
worker
consum
environ
propos
valuabl
strategi
use
arb
drug
address
potenti
acut
lung
injuri
might
induc
applic
pamam
see
figur
previou
page
figur
downregul
express
mice
challeng
cation
pamam
dendrim
level
angii
plasma
vehicl
control
nanoparticletr
mice
hr
administr
angii
level
determin
use
radioimmunoassay
n
mice
per
group
p
p
comparison
group
vehicl
control
group
twotail
ttest
b
mrna
rel
express
level
vehicl
control
nanoparticletr
mice
hr
administr
data
normal
express
refer
gene
twotail
ttest
c
western
blot
total
lung
sampl
obtain
hr
instil
nanoparticl
blot
repres
three
differ
mice
treatment
quantit
analys
ace
protein
level
illustr
level
shown
mean
aceand
ratio
sem
n
mice
per
treatment
p
comparison
group
vehicl
group
twotail
ttest
bind
nanoparticl
recombin
human
differ
concentr
measur
surfac
plasmon
reson
spr
detail
dynam
bind
constant
equilibrium
dissoci
constant
shown
tabl
e
nanoparticl
differ
concentr
incub
recombin
angii
level
angii
enzymat
activ
measur
system
determin
radioimmunoassay
n
test
per
group
twotail
ttest
data
shown
mean
valu
sem
p
p
ns
mean
signific
show
cation
pamam
dendrim
nanoparticl
trigger
acut
lung
failur
mice
mechanist
cation
nanoparticl
bind
downregul
function
express
lung
tissu
result
deregul
ra
importantli
administr
losartan
amelior
nanoparticleinduc
lung
injuri
new
insight
molecular
pathogenesi
cation
pamam
nanoparticleinduc
lung
failur
might
therefor
contribut
better
understand
nanoparticl
toxic
develop
improv
safeti
procedur
nanomateri
arb
drug
long
histor
applic
hypertens
result
uncov
import
pathway
cation
pamam
nanoparticleinduc
lung
toxic
may
allow
translat
find
novel
therapi
use
classic
arb
drug
pamam
dendrim
carbon
nanotub
inorgan
nanoparticl
powder
purchas
sigmaaldrich
pamam
nanoparticl
airdri
superclean
bench
hr
remov
methanol
equal
volum
pb
ad
tube
sampl
mix
store
use
antiac
antibodi
purchas
santa
cruz
biotechnolog
inc
antibodi
clone
recombin
human
protein
purchas
r
system
antibodi
clone
angiotensin
ii
human
losartan
evan
blue
purchas
sigmaaldrich
hspegcooh
mw
da
mw
da
hs
mw
da
purchas
shanghai
yare
biotechnolog
inc
hydrochlorid
edc
nhydroxysuccinimid
nh
ethanol
naoh
ethanolamin
purchas
sigmaaldrich
reagent
use
without
purif
milliq
water
obtain
millipor
elix
water
purif
system
buffer
reagent
use
degass
filter
prior
use
spr
experi
mice
j
background
develop
mous
previous
describ
j
mice
purchas
vital
river
beij
mice
week
old
anim
experi
conduct
anim
facil
institut
basic
medic
scienc
peke
union
medic
colleg
accord
local
institut
guidelin
lung
injuri
induc
mice
intratrach
instil
nanoparticl
concentr
use
technolog
previous
describ
sar
spike
proteinand
acidinduc
lung
injuri
rescu
experi
losartan
mgkg
pb
inject
intraperiton
min
nanoparticl
administr
total
male
mice
divid
six
group
six
mice
randomli
allot
control
pamam
nanoparticl
group
pb
use
group
control
mice
group
ii
iii
iv
v
vi
intratrach
inject
pamam
nanoparticl
concentr
respect
anim
observ
hr
administr
nanoparticl
mortal
rate
record
valu
cl
calcul
use
improv
karber
method
confid
limit
mice
instil
intratrach
nanoparticl
concentr
assess
extent
pulmonari
edema
hr
later
lung
wettodri
weight
ratio
calcul
brief
blood
drain
excis
lung
wet
weight
lung
measur
lung
heat
oven
hr
weigh
determin
baselin
dri
mass
lung
tail
ttest
e
repres
lung
patholog
wt
ko
mice
hr
administr
vehicl
control
pamam
number
infiltr
cell
per
microscop
field
sem
also
shown
n
field
analyz
three
mice
treatment
twotail
ttest
scale
bar
data
shown
mean
valu
sem
except
surviv
curv
p
p
mice
intratrach
inject
either
vehicl
nanoparticl
surviv
group
record
hr
plot
use
kaplanmei
surviv
curv
rescu
group
losartan
intraperiton
inject
min
nanoparticl
administr
mice
intratrach
inject
nanoparticl
concentr
ten
hour
later
blood
sampl
obtain
common
carotid
arteri
pao
measur
radiomet
blood
ga
analyz
diamond
diagnosticsusa
assess
arteri
blood
oxygen
indic
respiratori
failur
mice
anesthet
sodium
pentobarbit
either
vehicl
control
nanoparticl
dissolv
vehicl
administ
intratrach
lung
elast
measur
buxco
pulmonari
function
test
pft
everi
min
spontan
breath
period
hr
rescu
group
losartan
mgkg
intraperiton
inject
min
nanoparticl
administr
ten
hour
administr
nanoparticl
mice
sacrif
bodi
weight
determin
lung
remov
thorac
caviti
place
glass
vial
contain
approxim
ml
fix
glass
vial
assign
number
unknown
pathologist
lung
fix
least
hr
formalin
embed
paraffin
thinsect
coron
mount
glass
slide
use
standard
histopatholog
techniqu
section
stain
hematoxylin
eosin
mous
lung
section
examin
independ
three
pathologist
follow
induct
lung
injuri
pulmonari
vascular
permeabl
assess
measur
pulmonari
extravas
evan
blue
evan
blue
inject
tail
vein
hr
intratrach
inject
nanoparticl
ten
minut
later
anim
sacrif
lung
remov
thorac
caviti
perfus
icecold
pb
via
inject
right
ventricl
lung
tissu
immers
formamid
analyz
determin
evan
blue
content
od
valu
evan
blue
formamid
solut
read
use
micropl
spectrophotomet
nm
standard
concentr
regress
curv
creat
use
determin
level
evan
blue
lung
tissu
mice
intratrach
inject
nanoparticl
blood
collect
hr
later
ml
tube
contain
mixtur
peptidas
inhibitor
ethylenediaminetetraacet
acid
dimercaprol
sulfat
radioimmunoassay
determin
level
angiotensin
peptid
plasma
extract
perform
describ
previous
rescu
group
losartan
mgkg
intraperiton
inject
min
nanoparticl
administr
realtim
quantit
pcr
lung
tissu
obtain
hr
intratrach
inject
nanoparticl
homogen
use
trizol
reagent
invitrogen
rna
extract
accord
manufactur
instruct
complementari
dna
cdna
synthes
total
rna
high
capac
cdna
revers
transcript
kit
appli
biosystem
pcr
amplif
assay
perform
lightcycl
sybr
green
master
roch
appli
scienc
lightcycl
pcr
system
roch
appli
scienc
pcr
product
confirm
sequenc
lung
tissu
sampl
normal
level
specif
primer
use
list
follow
mous
forward
primer
mous
revers
primer
forward
primer
revers
primer
see
figur
previou
page
figur
losartan
reduc
sever
pamam
nanoparticleinduc
acut
lung
injuri
surviv
rate
indic
time
logrank
test
b
percent
chang
lung
elast
indic
time
anova
bonferroni
post
hoc
analys
c
plasma
angii
level
hr
twotail
ttest
lung
wettodri
weight
ratio
hr
twotail
ttest
e
blood
oxygen
hr
twotail
ttest
f
vascular
leakag
hr
twotail
ttest
g
histopatholog
lung
infiltr
cell
count
hr
h
concentr
balf
hr
control
wt
mice
wt
mice
treat
pamam
nanoparticl
wt
mice
treat
pamam
nanoparticl
plu
losartan
mgkg
ip
n
mice
per
group
twotail
ttest
g
repres
lung
histopatholog
mean
number
lunginfiltr
cell
sem
per
microscop
field
field
analyz
n
mice
per
group
shown
scale
bar
data
shown
mean
valu
sem
except
surviv
curv
p
p
nd
mean
detect
lung
sampl
obtain
hr
intratrach
inject
nanoparticl
homogen
icecold
lysi
buffer
mm
trishcl
ph
mm
nacl
triton
mm
edta
mm
na
vo
mm
naf
proteas
inhibitor
tissu
lysat
separ
sdspage
protein
transfer
nc
membran
membran
incub
antibodi
ace
follow
incub
horseradish
peroxidaseconjug
secondari
antibodi
band
intens
analyz
use
quantiti
one
softwar
immobil
analyt
amino
terminu
hspegcooh
hs
molar
ratio
total
concentr
mm
print
bare
gold
spri
chip
immobil
analyt
carboxyl
terminu
hs
molar
ratio
print
bare
gold
spri
chip
total
concentr
mm
chip
incub
wet
air
hr
allow
format
uniform
selfassembl
monolay
chip
wash
deioniz
water
ethanol
dri
stream
n
activ
edcnh
min
realtim
detect
protein
adsorpt
perform
use
plexera
spri
apparatu
plexera
bioscienc
llc
usa
entir
spri
chip
surfac
imag
angular
scan
immobil
analyt
spot
diamet
spri
chip
select
work
optic
posit
automat
calcul
accord
plasma
curv
autoinject
system
control
flow
rate
pb
ph
use
run
buffer
baselin
obtain
protein
differ
concentr
inject
flow
cell
naoh
mm
use
regener
solut
kinet
analysi
plexera
evalu
softwar
use
fit
spr
curv
langmuir
equat
recombin
human
protein
ngml
incub
without
mgml
differ
nanoparticl
assay
buffer
mm
tri
nacl
ph
min
ad
angiotensin
ii
pgml
addit
min
except
blank
control
sampl
radioimmunoassay
determin
level
angiotensin
ii
peptid
assay
buffer
perform
describ
previous
bronchoalveolar
lavag
fluid
balf
obtain
hr
intratrach
inject
nanoparticl
concentr
balf
determin
elisa
r
system
accord
manufactur
instruct
rescu
group
losartan
mgkg
intraperiton
inject
min
nanoparticl
administr
data
shown
mean
valu
sem
measur
singl
time
point
analyz
anova
demonstr
signific
analyz
use
twotail
ttest
time
cours
analyz
use
repeat
measur
mix
model
anova
bonferroni
posthoc
analys
statist
test
conduct
use
graphpad
prism
graphpad
softwar
san
diego
ca
usa
valu
p
use
indic
statist
signific
addit
file
tabl
physicalchem
characterist
pamam
use
studi
addit
file
figur
effect
variou
nanomateri
express
plasma
angiotensin
ii
level
plasma
angii
level
mice
receiv
vehicl
control
mice
instil
indic
nanoparticl
use
hr
challeng
n
mice
per
group
b
ace
protein
level
lung
hr
instil
indic
nanoparticl
upper
panel
show
repres
western
blot
bar
graph
show
ace
level
ratio
n
mice
per
group
data
shown
mean
valu
sem
b
differ
detect
nanoparticletr
group
vehicl
control
group
use
twotail
ttest
addit
file
figur
spr
signal
cation
polyamidoamin
dendrim
nanoparticl
combin
bind
abil
nanoparticl
recombin
differ
concentr
measur
surfac
plasmon
reson
spr
detail
dynam
bind
constant
equilibrium
dissoci
constant
shown
addit
file
tabl
addit
file
tabl
kinet
paramet
bind
cation
polyamidoamin
dendrim
nanoparticl
bind
cation
polyamidoamin
dendrim
nanoparticl
includ
cation
polym
anionicpolym
recombin
assess
use
spr
detail
data
ka
dynam
bind
constant
kd
dynam
dissoci
constant
ka
equilibrium
bind
constant
kd
equilibrium
dissoci
constant
indic
nd
indic
spr
signal
detect
